Skip to main content
Clinical Trials/CTRI/2019/06/019721
CTRI/2019/06/019721
Not yet recruiting
Phase 1

EFFICACY OF TRIPHALA-AMRTAADI KVATHA PANA IN THE MANAGEMENT OF DIABETIC RETINOPATHY- A RANDOMIZED CONTROLLED CLINICAL TRIA

KAHERs Shri BMK Ayurveda Mahavidyalaya0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: H30-H36- Disorders of choroid and retina
Sponsor
KAHERs Shri BMK Ayurveda Mahavidyalaya
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
KAHERs Shri BMK Ayurveda Mahavidyalaya

Eligibility Criteria

Inclusion Criteria

  • Patients presenting with clinically established condition of Diabetic Retinopathy
  • Patients with Non proliferative diabetic retinopathy of mild to moderate changes
  • Patients of DM (Type 1\&Type 2\) between the ages 20\-70years having ophthalmoscopically detectable DR changes.
  • Patients on anti diabetic treatment and good glycemic control.

Exclusion Criteria

  • Patient with Severe NPDR, proliferative diabetic retinopathy, high risk proliferative diabetic retinopathy, Diabetic maculopathy, advanced diabetic eye disease, and retinopathies of other origin will be excluded.
  • Known patients of Glaucoma and any ophthalmic infective conditions will be excluded.
  • Patients with Aided Visual Acuity less than 6/60 at Snellenâ??s distant chart.
  • Patients with other systemic disorders like renal diseases, chronic uncontrolled hyperglycaemia and hyperlipidaemia, cardiovascular diseases etc will be excluded.
  • Extremely debilitated patients and in pregnancy .

Outcomes

Primary Outcomes

Not specified

Similar Trials